Skip to content

Coenzyme Q10 and blood pressure: grade C

Limited evidence. Direction: No effect.

C Limited

Why this grade

Rubric condition met: The rubric cap: clinical-only evidence (hypertension, cardiometabolic disorders); conflicting meta-analyses, so direction none

A 2016 Cochrane review pooled 2 RCTs (50 participants) with primary hypertension and found no significant change, rating this moderate-quality evidence of no clinically significant effect. A 2022 meta-analysis of 26 studies in cardiometabolic disorders found systolic pressure fell by 4.77 mmHg, while a 2026 meta-analysis of 20 RCTs in prediabetes and type 2 diabetes found no significant effect. The larger falls in a 2007 meta-analysis rest on before-after comparisons and open-label studies. No trials in people with normal blood pressure are cited.

How we grade evidence

Studies this grade rests on

EffectMixedNo effectSize shows participants (n)200520102015202020252030Meta-analysisZhao 2022, 2022: meta-analysis, n = 1,831, result not recordedRosenfeldt 2007, 2007: meta-analysis, n = 362, result not recordedHo 2016, 2016: meta-analysis, n = 50, result not recordedRezagholizadeh 2026, 2026: meta-analysis, n not recorded, result not recorded
each study this grade rests on, by publication year and design. Solid: effect versus the comparator; half-filled: mixed; hollow: no effect; dashed: result not recorded yet. Larger marks had more participants.
Show the numbers
StudyYearDesignParticipantsResult
Rosenfeldt 20072007meta-analysis362result not recorded
Ho 20162016meta-analysis50result not recorded
Zhao 20222022meta-analysis1831result not recorded
Rezagholizadeh 20262026meta-analysisnot recordedresult not recorded

Coenzyme Q10 in the treatment of hypertension: a meta-analysis of the clinical trials.

Rosenfeldt FL, Haas SJ, Krum H. Coenzyme Q10 in the treatment of hypertension: a meta-analysis of the clinical trials J Hum Hypertens, 2007. PMID 17287847

Result not recorded
Design
Meta-analysis of 12 clinical trials (3 RCTs, 1 crossover, 8 open-label)
Sample
n = 362
Population
Patients with hypertension (clinical population)
Funding
Funding: not stated in the PubMed or Crossref record; full text not read.

The effect of CoQ10 supplementation on cardiovascular risk factors in patients with prediabetes and type 2 diabetes mellitus: a grade-assessed systematic review and dose-response meta-analysis.

Rezagholizadeh F, Rezvani S, Oskouie FH. The effect of CoQ10 supplementation on cardiovascular risk factors in patients with prediabetes and type 2 diabetes mellitus: a grade-assessed systematic review and dose-response meta-analysis BMC Pharmacol Toxicol, 2026. PMID 42642774

Result not recorded
Design
Systematic review and meta-analysis of 20 RCTs
Population
Patients with prediabetes or type 2 diabetes (clinical population)
Funding
Funding: not stated in the PubMed or Crossref record; full text not read.

Dose-Response Effect of Coenzyme Q10 Supplementation on Blood Pressure among Patients with Cardiometabolic Disorders: A Grading of Recommendations Assessment, Development, and Evaluation (GRADE)-Assessed Systematic Review and Meta-Analysis of Randomized Controlled Trials.

Zhao D, Liang Y, Dai S. Dose-Response Effect of Coenzyme Q10 Supplementation on Blood Pressure among Patients with Cardiometabolic Disorders: A Grading of Recommendations Assessment, Development, and Evaluation (GRADE)-Assessed Systematic Review and Meta-Analysis of Randomized Controlled Trials Adv Nutr, 2022. PMID 36130103

Result not recorded
Design
GRADE-assessed systematic review and dose-response meta-analysis of 26 studies
Sample
n = 1,831
Population
Patients with cardiometabolic disorders (clinical population)
Funding
National Natural Science Foundation of China (Crossref funder record)

Blood pressure lowering efficacy of coenzyme Q10 for primary hypertension.

Ho MJ, Li EC, Wright JM. Blood pressure lowering efficacy of coenzyme Q10 for primary hypertension Cochrane Database Syst Rev, 2016. PMID 26935713

Result not recorded
Design
Cochrane systematic review; meta-analysis of 2 RCTs
Sample
n = 50
Population
Adults with primary hypertension (clinical population)
Funding
Canadian Institutes of Health Research (PubMed grant list)

Search and history

Search (): (coenzyme Q10[ti] OR CoQ10[ti] OR ubiquinol[ti]) AND (blood pressure[tiab] OR hypertension[tiab]) AND (meta-analysis[pt] OR systematic review[pt])

  • Graded C (proposed): Proposed in the monograph draft
  • C to C (approved): Editor sign-off November 13, 2026: grade matches the editor-approved final page